Everbright Securities Maintains "Buy" Rating on ASMPT (00522), Expects Accelerated TCB Equipment Shipments in Q4 2025 and 2026

Stock News
2025/10/30

Everbright Securities has reiterated its "Buy" rating on ASMPT (00522), citing strong AI demand, recovery in core businesses and SMT operations, and anticipated acceleration in TCB equipment shipments in Q4 2025 and 2026. However, restructuring-related one-time expenses have led to adjustments in the company's net profit forecasts for 2025–2027 to HKD 203 million, HKD 1.351 billion, and HKD 1.935 billion, respectively (representing a -66%, +42%, and +41% revision compared to previous estimates), with year-on-year growth rates of -41.2%, +565.2%, and +43.2%.

The report highlights ASMPT's progress in TCB and HB equipment, with expectations of bulk shipments to leading foundry customers. The launch of HBM4 and 16-layer HBM is expected to further boost TCB demand, reinforcing long-term optimism for the advanced packaging business's positive impact on performance and valuation.

Key developments include: 1) **TCB**: The company has secured validation from a major logic sector client and holds a first-mover advantage in HBM4. - In the logic sector, ASMPT is poised to receive orders from a top foundry customer and partners for C2S in Q4 2025 and beyond, while C2W solutions have already passed customer certification for mass production. - In memory, ASMPT has received orders from multiple clients for HBM4-12H, with one being the primary supplier. Its flux-free TCB (AOR) technology is also positioned for future 16-layer HBM production.

2) **HB**: Deliveries continued in Q3, with several collaborative projects at various evaluation stages.

Additionally, the voluntary liquidation of its Shenzhen subsidiary, AEC, resulted in a short-term loss due to restructuring and inventory write-offs totaling HKD 355 million in Q3. However, this move is expected to improve long-term profitability, with projected annual cost savings of HKD 128 million and enhanced gross margins post-completion.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10